Ex vivo assays of CEM cells cultured and treated in the three dimensional cultures

Biomedicine and Pharmacotherapy

Volumn 64, Issue 6, 2010, Pages 390-395

  Bartusik, Dorota ^a,b   Tomanek, Boguslaw ^a,b,c,d   Lattová, Erika ^e   Perreault, Hélène ^e   Fallone, Gino ^b,d  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b CROSS CANCER INSTITUTE   (Canada)

^c INSTITUTE OF NUCLEAR PHYSICS   (Poland)

^d UNIVERSITY OF ALBERTA   (Canada)

^e UNIVERSITY OF MANITOBA   (Canada)

Author keywords

CEM cells; Magnetic resonance imaging; Matrix assisted laser desorption

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; GLYCOPEPTIDE; LIPOFECTAMINE; LIPOPLEX; PLASMID DNA; TRASTUZUMAB;

ARTICLE; BIOREACTOR; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; EX VIVO STUDY; HOLLOW FIBER REACTOR; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECEPTOR BINDING;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; BIOREACTORS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; GLYCOPEPTIDES; HUMANS; LIPIDS; MAGNETIC RESONANCE IMAGING; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RECEPTOR, ERBB-2; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; T-LYMPHOCYTES;

EID: 77954309626     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2010.02.004     Document Type: Article

References (33)

1. Griffith L.G., Swartz M.A. Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol 2006, 7:211-224.
2. Abbott A. Biology's new dimension. Nature 2003, 424:870-872.
3. Fata J.E., Ho A.T., Leco K.J., Moorehead R.A., Khokha R. Cellular turnover and extracellular matrix remodeling in female reproductive tissues: functions of metalloproteinases and their inhibitors. Cell Mol Life Sci 2000, 57:77-95.
4. Cukierman E., Pankov E., Stevens D.R., Yamanda K.M. Taking cell-matrix adhesions to the third dimension. Science 2001, 294:1708-1712.
5. Takezawa T., Mori Y., Yonaha T., Yoshizato K. Characterization of morphology and cellular metabolism during the spheroid formation by fibroblasts. Exp Cell Res 1993, 208:430-441.
6. Ivascu A., Kubbies M. Diversity of cell-mediated adhesions in breast cancer spheroids. Int J Oncol 2007, 31:1403-1413.
7. DeBartolo L, Drioli. Membranes in artificial organs. in: P.I. Haris, D. Chapman (eds.), Biomedical and Health Research: New Biomedical Materials-Basic and Applied Studies, IOS Press, Amsterdam/Berlin/Oxford/Tokyo/Washington, 1998, pp. 167-81.
8. Zuhorn I.S., Kalicharan D., Robillard G.T., Hoekstra D. Adhesion receptors mediate efficient non-viral gene delivery. Mol Therapy 2007, 15:946-953.
9. Felgner J.H., Kumar R., Sridhar C.N., Wheeler C.J., Tsai Y.J., Border R., et al. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem 1994, 269:2550-2561.
10. Kirstein M.N., Brundage R.C., Elmquist W.F., Remmel R.P., Marker P.H., Guire D.E., et al. Characterization of an in vitro cell culture bioreactor system to evaluate anti-neoplastic drug regimens. Breast Cancer Res Treat 2006, 96:203-301.
11. Plowman G.D., Green J.M., Culouscou J.M., Carlton G.W., Rothwell V.M., Buckley S. Heregulin induces tyrosine phosphorylation of HER4/pl8OerbB4. Nature 1993, 366:473-475.
12. Riese D.J., van Raaij T.M., Plowman G.D., Andrews G.C., Stern D.F. The cellular response to neuregulins is governed by complex interactions of the erbB receptor family. Mol Cell Biol 1995, 15:5770-5776.
13. Kono K., Rongcun Y. Identification of HER2/neuderived peptide epitopes recognized by gastric cancer-specific CTLs. Charo J. Int J Cancer 1998, 78:202-208.
14. Takahashi K., Loo G. Disruption of mitochondria during tocotrienol-induced apoptosis in MDAMB-231 human breast cancer cells. Biochem Pharm 2004, 67:315-324.
15. Xu L., Frederik P., Pirollo K.F., Tang W.H., Rait A., Xiang L.M., et al. Self-assembly of a virus-mimicking nanostructure system for efficient tumor-targeted gene delivery. Hum Gene Ther 2002, 13:469-481.
16. Loboda A.V., Krutchinsky N.N., Bromirski M.P., Ens W., Standing K.G. A tandem quadrupole/time-offlight mass spectrometer with a matrix-assisted laser desorption/ionization source: design and performance. Rapid Commun Mass Spectrom 2000, 14:1047-1057.
17. Lattová E., Kapková P., Krokhin O., Perreault H. Method for investigation of oligosaccharides from glycopeptides: direct determination of glycosylation sites in proteins. Anal Chem 2006, 78:2977-2984.
18. Lattová E., Varma S., Bezabeh T., Perreault H. Matrix-assisted laser desorption/ionization on-target method for the investigation of oligosaccharides and glycosylation sites in glycopeptides and glycoproteins. Rapid Commun Mass Spectrom 2007, 21:1644-1650.
19. Guenther M.G., Jenner R.G., Chevalier B., Nakamura T., Croce C.M., Canaani E., et al. Global and Hox-specific roles for the MLL1 methyltransferase. Proc Natl Acad Sci U S A 2005, 102(24):8603-8608.
20. Richie-Jannetta R., Busch J.L., Higgins K.A., Corbin J.D., Francis S.H. Isolated regulatory domains of cGMP-dependent protein kinase Ialpha and Ibeta retain dimerization and native cGMP-binding properties and undergo isoform-specific conformational changes. J Biol Chem 2006, 281(11):6977-6984.
21. Laederich M.B., Funes-Duran M., Yen L., Ingalla E., Wu X., Carraway K.L., et al. The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases. Biol Chem 2004, 279(45):47050-47056.
22. Duan C., Clemmons D.R. Transcription factor AP-2 regulates human insulin-like growth factor binding protein-5 gene expression. J Biol Chem 1995, 270(42):24844-24851.
23. Posting H., Hilschmann N. The rule of antibody structure. Hoppe Seylers Z Physiol Chem 1976, 357:1571-1604.
24. McCarthy N.J., Evan G.I. Methods for detecting and quantifying apoptosis. Curr Top Dev Biol 1998, 36:259-278.
25. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972, 26:239-257.
26. Martin Y., Vermette P. Bioreactors for tissue mass culture: design, characterization, and recent advances. Biomaterials 2005, 26:7481-7503.
27. Hynes N.E., Stern D.F. Biological effects of anti-ErbB2 single chain antibodies selected for internalizing function. Biochim Biophys Acta 1994, 1198:165-184.
28. Mahato R.J., Henry J., Narang A.S., Sabek O., Fraga D., Kotb M., et al. Cationic lipid and polymer-based gene delivery to human pancreatic islets. Mol Therapy 2003, 7:89-100.
29. Dalby B., Cates S., Harris A., Ohki E.C., Tilkins M.L., Price P.J., et al. Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications. Methods 2004, 33:95-103.
30. Thomasson M., Hedman H., Guo D., Ljungberg B., Henriksson R. LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT-PCR and immunohistochemical analysis. Br J Cancer 2003, 89:1285-1289.
31. Hedman H., Nilsson J., Guo D., Henriksson R. Is LRIG1 a tumour suppressor gene at chromosome 3p14. 3?. Acta Oncol 2002, 41:352-354.
32. Li M., Wang Y., Hung M.C., Kannan P. Inefficient proteasomaldegradation pathway stabilizes AP-2 alpha and activates HER-2/neu gene in breast cancer. Int J Cancer 2006, 118:802-811.
33. Akao T., Fukumoto T., Ihara H., Ito A. Conformational changes in DNA induced by cationic bilayer membranes. FEBS Lett 1996, 391:215-218.